| Hale Le'a Medicine | |
|
2460 Oka St 101-a Kilauea HI 96754-5308 | |
| (808) 828-2882 | |
| (808) 828-0119 |
| Full Name | Hale Le'a Medicine |
|---|---|
| Speciality | Clinic/Center |
| Location | 2460 Oka St, Kilauea, Hawaii |
| Authorized Official Name and Position | Steve M Rogoff (PARTNER) |
| Authorized Official Contact | 8088282885 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Hale Le'a Medicine 2460 Oka St 101-a Kilauea HI 96754-5308 Ph: (808) 828-2882 | Hale Le'a Medicine 2460 Oka St 101-a Kilauea HI 96754-5308 Ph: (808) 828-2882 |
| NPI Number | 1659531622 |
|---|---|
| Provider Enumeration Date | 06/13/2008 |
| Last Update Date | 06/13/2008 |
| Medicare PECOS PAC ID | 7012070774 |
|---|---|
| Medicare Enrollment ID | O20090107000415 |
News Archive
Certain cells from a mother persist in their children's bodies and can provoke an immune response in which the child's body attacks itself, according to Mayo Clinic research published in the current issue of the Journal of Immunology (http://www.jimmunol.org).
US attendings would like formal policies governing smartphone use during rounds, show the results of a survey that highlight the potential for smartphones to cause distraction, as well as being useful in this setting.
The study published in the August 2004 issue of the Journal of Nutrition compared the bioavailability of lutein from various sources, in order to determine how it can impact dietary recommendations. Highly bioavailable forms of nutrients are those that the body can most easily absorb and utilize.
pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application to treat posterior uveitis with pSivida's injectable sustained-release micro-insert.
› Verified 6 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659531622 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QC1500X | Clinic/center - Community Health | 11990 (Hawaii) | Primary |
| Provider Name | Arthur H Brownstein |
|---|---|
| Provider Type | Practitioner - Preventive Medicine |
| Provider Identifiers | NPI Number: 1831391051 PECOS PAC ID: 4284691676 Enrollment ID: I20041217000017 |
News Archive
Certain cells from a mother persist in their children's bodies and can provoke an immune response in which the child's body attacks itself, according to Mayo Clinic research published in the current issue of the Journal of Immunology (http://www.jimmunol.org).
US attendings would like formal policies governing smartphone use during rounds, show the results of a survey that highlight the potential for smartphones to cause distraction, as well as being useful in this setting.
The study published in the August 2004 issue of the Journal of Nutrition compared the bioavailability of lutein from various sources, in order to determine how it can impact dietary recommendations. Highly bioavailable forms of nutrients are those that the body can most easily absorb and utilize.
pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application to treat posterior uveitis with pSivida's injectable sustained-release micro-insert.
› Verified 6 days ago
| Provider Name | Todd L Strong |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1689894156 PECOS PAC ID: 4981799640 Enrollment ID: I20071029000294 |
News Archive
Certain cells from a mother persist in their children's bodies and can provoke an immune response in which the child's body attacks itself, according to Mayo Clinic research published in the current issue of the Journal of Immunology (http://www.jimmunol.org).
US attendings would like formal policies governing smartphone use during rounds, show the results of a survey that highlight the potential for smartphones to cause distraction, as well as being useful in this setting.
The study published in the August 2004 issue of the Journal of Nutrition compared the bioavailability of lutein from various sources, in order to determine how it can impact dietary recommendations. Highly bioavailable forms of nutrients are those that the body can most easily absorb and utilize.
pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application to treat posterior uveitis with pSivida's injectable sustained-release micro-insert.
› Verified 6 days ago
| Provider Name | Steve M Rogoff |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1487698924 PECOS PAC ID: 0345303004 Enrollment ID: I20090213000425 |
News Archive
Certain cells from a mother persist in their children's bodies and can provoke an immune response in which the child's body attacks itself, according to Mayo Clinic research published in the current issue of the Journal of Immunology (http://www.jimmunol.org).
US attendings would like formal policies governing smartphone use during rounds, show the results of a survey that highlight the potential for smartphones to cause distraction, as well as being useful in this setting.
The study published in the August 2004 issue of the Journal of Nutrition compared the bioavailability of lutein from various sources, in order to determine how it can impact dietary recommendations. Highly bioavailable forms of nutrients are those that the body can most easily absorb and utilize.
pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application to treat posterior uveitis with pSivida's injectable sustained-release micro-insert.
› Verified 6 days ago
| Provider Name | Cooper C Schraudenbach |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1790848299 PECOS PAC ID: 1456440064 Enrollment ID: I20100414000608 |
News Archive
Certain cells from a mother persist in their children's bodies and can provoke an immune response in which the child's body attacks itself, according to Mayo Clinic research published in the current issue of the Journal of Immunology (http://www.jimmunol.org).
US attendings would like formal policies governing smartphone use during rounds, show the results of a survey that highlight the potential for smartphones to cause distraction, as well as being useful in this setting.
The study published in the August 2004 issue of the Journal of Nutrition compared the bioavailability of lutein from various sources, in order to determine how it can impact dietary recommendations. Highly bioavailable forms of nutrients are those that the body can most easily absorb and utilize.
pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application to treat posterior uveitis with pSivida's injectable sustained-release micro-insert.
› Verified 6 days ago
| Provider Name | Mary Lucille Cameron |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1184623605 PECOS PAC ID: 5799740619 Enrollment ID: I20120723000649 |
News Archive
Certain cells from a mother persist in their children's bodies and can provoke an immune response in which the child's body attacks itself, according to Mayo Clinic research published in the current issue of the Journal of Immunology (http://www.jimmunol.org).
US attendings would like formal policies governing smartphone use during rounds, show the results of a survey that highlight the potential for smartphones to cause distraction, as well as being useful in this setting.
The study published in the August 2004 issue of the Journal of Nutrition compared the bioavailability of lutein from various sources, in order to determine how it can impact dietary recommendations. Highly bioavailable forms of nutrients are those that the body can most easily absorb and utilize.
pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application to treat posterior uveitis with pSivida's injectable sustained-release micro-insert.
› Verified 6 days ago
| Provider Name | Emelia L Haraguchi |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1841567179 PECOS PAC ID: 3476715285 Enrollment ID: I20121009000623 |
News Archive
Certain cells from a mother persist in their children's bodies and can provoke an immune response in which the child's body attacks itself, according to Mayo Clinic research published in the current issue of the Journal of Immunology (http://www.jimmunol.org).
US attendings would like formal policies governing smartphone use during rounds, show the results of a survey that highlight the potential for smartphones to cause distraction, as well as being useful in this setting.
The study published in the August 2004 issue of the Journal of Nutrition compared the bioavailability of lutein from various sources, in order to determine how it can impact dietary recommendations. Highly bioavailable forms of nutrients are those that the body can most easily absorb and utilize.
pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application to treat posterior uveitis with pSivida's injectable sustained-release micro-insert.
› Verified 6 days ago
| Provider Name | Kalani S Walther |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1639278252 PECOS PAC ID: 3971504382 Enrollment ID: I20151116000785 |
News Archive
Certain cells from a mother persist in their children's bodies and can provoke an immune response in which the child's body attacks itself, according to Mayo Clinic research published in the current issue of the Journal of Immunology (http://www.jimmunol.org).
US attendings would like formal policies governing smartphone use during rounds, show the results of a survey that highlight the potential for smartphones to cause distraction, as well as being useful in this setting.
The study published in the August 2004 issue of the Journal of Nutrition compared the bioavailability of lutein from various sources, in order to determine how it can impact dietary recommendations. Highly bioavailable forms of nutrients are those that the body can most easily absorb and utilize.
pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application to treat posterior uveitis with pSivida's injectable sustained-release micro-insert.
› Verified 6 days ago
| Provider Name | Daniel S Dinenberg |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1811169063 PECOS PAC ID: 0648334631 Enrollment ID: I20180621001970 |
News Archive
Certain cells from a mother persist in their children's bodies and can provoke an immune response in which the child's body attacks itself, according to Mayo Clinic research published in the current issue of the Journal of Immunology (http://www.jimmunol.org).
US attendings would like formal policies governing smartphone use during rounds, show the results of a survey that highlight the potential for smartphones to cause distraction, as well as being useful in this setting.
The study published in the August 2004 issue of the Journal of Nutrition compared the bioavailability of lutein from various sources, in order to determine how it can impact dietary recommendations. Highly bioavailable forms of nutrients are those that the body can most easily absorb and utilize.
pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application to treat posterior uveitis with pSivida's injectable sustained-release micro-insert.
› Verified 6 days ago
| Provider Name | Kambria Beck Holder |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1689873184 PECOS PAC ID: 9133268923 Enrollment ID: I20220623001018 |
News Archive
Certain cells from a mother persist in their children's bodies and can provoke an immune response in which the child's body attacks itself, according to Mayo Clinic research published in the current issue of the Journal of Immunology (http://www.jimmunol.org).
US attendings would like formal policies governing smartphone use during rounds, show the results of a survey that highlight the potential for smartphones to cause distraction, as well as being useful in this setting.
The study published in the August 2004 issue of the Journal of Nutrition compared the bioavailability of lutein from various sources, in order to determine how it can impact dietary recommendations. Highly bioavailable forms of nutrients are those that the body can most easily absorb and utilize.
pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application to treat posterior uveitis with pSivida's injectable sustained-release micro-insert.
› Verified 6 days ago
News Archive
Certain cells from a mother persist in their children's bodies and can provoke an immune response in which the child's body attacks itself, according to Mayo Clinic research published in the current issue of the Journal of Immunology (http://www.jimmunol.org).
US attendings would like formal policies governing smartphone use during rounds, show the results of a survey that highlight the potential for smartphones to cause distraction, as well as being useful in this setting.
The study published in the August 2004 issue of the Journal of Nutrition compared the bioavailability of lutein from various sources, in order to determine how it can impact dietary recommendations. Highly bioavailable forms of nutrients are those that the body can most easily absorb and utilize.
pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application to treat posterior uveitis with pSivida's injectable sustained-release micro-insert.
› Verified 6 days ago
Charlotte L Hunter, Md, Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2490 Oka St, Kilauea, HI 96754 Phone: 808-828-1418 Fax: 808-828-1666 | |
Capelli Corp Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2490 Oka St, Kilauea, HI 96754 Phone: 808-828-1418 Fax: 808-828-1666 | |
North Shore Medical Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2490 Oka St, Kilauea, HI 96754 Phone: 808-828-1418 Fax: 808-828-1666 | |
Rogoff Enterprises Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2490 Oka St, Kilauea, HI 96754 Phone: 808-828-1418 Fax: 808-828-1666 | |
Ohk Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2490 Oka St, Kilauea, HI 96754 Phone: 808-828-1418 | |
Melinda Menezes Md Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2490 Oka St, Kilauea, HI 96754 Phone: 808-828-1621 Fax: 808-828-1666 |